Which CFR Part governs Good manufacturing practices for finished pharmaceuticals?

Which CFR Part governs Good manufacturing practices for finished pharmaceuticals?

• A. 21 CFR Part 50
• B. 21 CFR Part 210
• C. 21 CFR Part 211
• D. 21 CFR Part 820

Answer: (C)

Focus on the standards that ensure the quality of a finished drug product. The regulation that specifically governs current Good Manufacturing Practice for finished pharmaceuticals is the part that sets the requirements for producing, processing, packaging, and holding finished drug products to ensure their quality and safety. It covers the entire lifecycle of the finished dosage form—from facilities, equipment, and personnel to validated processes, controlled documentation, batch records, testing, release, labeling, storage, and handling of deviations with appropriate corrective actions. This differs from the other options: one addresses protections for human subjects in research, another is a broader GMP framework for drugs that isn’t limited to finished dosage forms, and the last governs quality systems for medical devices, not pharmaceuticals.

Focus on the standards that ensure the quality of a finished drug product. The regulation that specifically governs current Good Manufacturing Practice for finished pharmaceuticals is the part that sets the requirements for producing, processing, packaging, and holding finished drug products to ensure their quality and safety. It covers the entire lifecycle of the finished dosage form—from facilities, equipment, and personnel to validated processes, controlled documentation, batch records, testing, release, labeling, storage, and handling of deviations with appropriate corrective actions.

This differs from the other options: one addresses protections for human subjects in research, another is a broader GMP framework for drugs that isn’t limited to finished dosage forms, and the last governs quality systems for medical devices, not pharmaceuticals.